ArticleOncotarget2018

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.

Kimberley Hanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.